サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1279722

睡眠障害治療の世界市場規模調査＆予測、薬剤タイプ別、用途別、地域別分析、2022-2029年

Global Sleep Disorders Treatment Market Size study & Forecast, by Drug Type by Application and Regional Analysis, 2022-2029
出版日: | 発行: Bizwit Research & Consulting LLP | ページ情報: 英文 | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
睡眠障害治療の世界市場規模調査＆予測、薬剤タイプ別、用途別、地域別分析、2022-2029年
出版日: 2023年05月09日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

睡眠障害治療市場は、不眠症、睡眠時無呼吸症候群、レストレスレッグ症候群などの睡眠障害の診断や治療に用いられる様々な製品やサービスを開発、生産、販売する産業を指します。

この市場には、医薬品、医療機器、行動療法が含まれます。睡眠障害治療の世界市場の主な促進要因は、睡眠障害の有病率の増加、高齢化人口の増加、睡眠障害に対する意識の高まりです。さらに、治療オプションの進歩や政府による有利な償還政策が、予測期間2022-2029年にかけて、市場に有利な成長機会を生み出しています。

睡眠障害の発生率の上昇と、これらの症状に対する一般的な知識の向上が、市場拡大の要因となっています。2022年と2023年の世界の不眠症の数に関するHelsestartのデータによると、米国の成人の半数が月に1回以上、不眠症があると報告しています。欧米は最も不眠症の影響を受けやすい地域で、成人の約59％が不眠を経験したことがあると推測されます。また、日本、台湾、スウェーデンの3カ国が最も不眠症に悩まされているとしています。2021年と2022年の2年間で、ノルウェーは人口10万人あたりのメラトニン問い合わせ数がスウェーデンより67件多く、世界的に見てもメラトニンの検索数が多い国となっています。しかし、睡眠障害治療のコストが高いため、2022年から2029年の予測期間を通じて市場の成長を阻害しています。

睡眠障害治療の世界市場調査において考慮された主要地域は、アジア太平洋地域、北米、欧州、中南米、世界のその他の地域です。北米は、睡眠障害の有病率の高さ、有利な償還政策、この地域における主要プレイヤーの存在により、睡眠障害治療の最大市場となっています。アジア太平洋地域は、睡眠障害の有病率の上昇、ヘルスケア支出の増加、大規模な患者プールの存在により、睡眠障害治療市場で大きな成長が見込まれています。

本調査の目的は、近年におけるさまざまなセグメントと国の市場規模を明らかにし、今後数年間の市場規模を予測することにあります。本レポートは、調査対象国の産業の質的・量的な側面を取り入れるよう設計されています。

また、市場の将来的な成長を規定する促進要因や課題など、重要な側面に関する詳細情報も提供しています。さらに、主要企業の競合情勢や薬剤の種類に関する詳細な分析とともに、利害関係者が投資するためのミクロ市場での潜在的な機会も組み込んでいます。.

目次

第1章 エグゼクティブサマリー

  • マーケットスナップショット
  • 世界・セグメント別市場推計・予測、2019年～2029年
    • 睡眠障害治療市場、地域別、2019年～2029年
    • 睡眠障害治療市場：薬物タイプ別、2019年～2029年
    • 睡眠障害治療市場：用途別、2019年-2029年
  • 主な動向
  • 予測手法
  • 調査の前提条件

第2章 睡眠障害治療の世界市場の定義と範囲

  • 調査目的
  • 市場の定義と範囲
    • 調査対象範囲
    • 産業の進化
  • 本調査の対象年
  • 通貨換算レート

第3章 睡眠障害治療市場の世界の力学

  • 睡眠障害治療市場の影響分析（2019年～2029年）
    • 市場促進要因
      • 睡眠障害の有病率の増加
      • 老年人口の増加
      • 睡眠障害に関する認知度の向上
    • 市場の課題
      • 睡眠障害の治療費の高騰
    • 市場機会
      • 治療法の進歩
      • 政府別好意的な保険償還政策

第4章 睡眠障害治療の世界市場産業分析

  • ポーターの5フォースモデル
    • 供給企業の交渉力
    • 買い手の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争企業間の敵対関係
  • ポーターの5フォースモデルの未来的アプローチ（2019年～2029年）
  • PEST分析
    • 政治的
    • 経済的
    • 社会的
    • 技術的
  • 投資採用モデル
  • アナリストの結論・提言
  • トップクラスの投資機会
  • 主要成功戦略

第5章 リスクアセスメント：COVID-19の影響

  • COVID-19が業界に与える全体的な影響についてのアセスメント
  • COVID-19以前とCOVID-19以後の市場シナリオ

第6章 睡眠障害治療の世界市場、薬剤タイプ別

  • 市場スナップショット
  • 睡眠障害治療の世界市場、薬物タイプ別、実績 - ポテンシャル分析
  • 睡眠障害治療の世界市場、薬物タイプ別推定・予測2019-2029
  • 睡眠障害治療市場、サブセグメント別分析
    • ベンゾジアゼピン系
    • 非ベンゾジアゼピン系
    • 抗うつ薬
    • その他の薬物タイプ

第7章 睡眠障害治療の世界市場：用途別

  • 市場スナップショット
  • 睡眠障害治療の世界市場：用途別、実績-ポテンシャル分析
  • 睡眠障害治療の世界市場、用途別、推定・予測2019-2029
  • 睡眠障害治療市場、サブセグメント別分析
    • 不眠症
    • 睡眠時無呼吸症候群（Sleep Apnea
    • ナルコレプシー
    • サーカディアン障害
    • その他の用途

第8章 睡眠障害治療の世界市場：地域別分析

  • 睡眠障害治療市場、地域別市場スナップショット
  • 北米
    • 米国
      • 薬剤タイプ別の推定・予測、2019年～2029年
      • アプリケーション別の推定・予測、2019年～2029年
    • カナダ
  • 欧州睡眠障害治療市場スナップショット
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • アジア太平洋地域の睡眠障害治療市場スナップショット
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカの睡眠障害治療市場スナップショット
    • ブラジル
    • メキシコ
  • 世界のその他の地域

第9章 競合情報

  • 主要市場戦略
  • 企業プロファイル
    • Takeda Pharmaceuticals USA Inc.
      • 主要情報
      • 概要
      • 財務（データの入手が可能な場合のみ）
      • 製品概要
      • 最近の動向
    • Vanda Pharmaceuticals Inc.
    • Merck & Co.
    • Mylan NV
    • Pfizer
    • Teva Pharmaceuticals USA Inc
    • Philips Healthcare
    • ResMed
    • Fisher & Paykel Healthcare
    • GlaxoSmithKline

第10章 調査プロセス

  • 調査プロセス
    • データマイニング
    • 分析
    • 市場推定
    • バリデーション
    • 出版
  • 調査の特徴
  • 調査の前提条件
図表

LIST OF TABLES

  • TABLE 1. Global Sleep Disorders Treatment Market, report scope
  • TABLE 2. Global Sleep Disorders Treatment Market estimates & forecasts by Region 2019-2029 (USD Billion)
  • TABLE 3. Global Sleep Disorders Treatment Market estimates & forecasts by Drug Type 2019-2029 (USD Billion)
  • TABLE 4. Global Sleep Disorders Treatment Market estimates & forecasts by Application 2019-2029 (USD Billion)
  • TABLE 5. Global Sleep Disorders Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 6. Global Sleep Disorders Treatment Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 7. Global Sleep Disorders Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 8. Global Sleep Disorders Treatment Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 9. Global Sleep Disorders Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 10. Global Sleep Disorders Treatment Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 11. Global Sleep Disorders Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 12. Global Sleep Disorders Treatment Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 13. Global Sleep Disorders Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 14. Global Sleep Disorders Treatment Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 15. U.S. Sleep Disorders Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 16. U.S. Sleep Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 17. U.S. Sleep Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 18. Canada Sleep Disorders Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 19. Canada Sleep Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 20. Canada Sleep Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 21. UK Sleep Disorders Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 22. UK Sleep Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 23. UK Sleep Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 24. Germany Sleep Disorders Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 25. Germany Sleep Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 26. Germany Sleep Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 27. France Sleep Disorders Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 28. France Sleep Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 29. France Sleep Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 30. Italy Sleep Disorders Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 31. Italy Sleep Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 32. Italy Sleep Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 33. Spain Sleep Disorders Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 34. Spain Sleep Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 35. Spain Sleep Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 36. RoE Sleep Disorders Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 37. RoE Sleep Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 38. RoE Sleep Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 39. China Sleep Disorders Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 40. China Sleep Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 41. China Sleep Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 42. India Sleep Disorders Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 43. India Sleep Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 44. India Sleep Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 45. Japan Sleep Disorders Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 46. Japan Sleep Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 47. Japan Sleep Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 48. South Korea Sleep Disorders Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 49. South Korea Sleep Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 50. South Korea Sleep Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 51. Australia Sleep Disorders Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 52. Australia Sleep Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 53. Australia Sleep Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 54. RoAPAC Sleep Disorders Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 55. RoAPAC Sleep Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 56. RoAPAC Sleep Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 57. Brazil Sleep Disorders Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 58. Brazil Sleep Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 59. Brazil Sleep Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 60. Mexico Sleep Disorders Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 61. Mexico Sleep Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 62. Mexico Sleep Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 63. RoLA Sleep Disorders Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 64. RoLA Sleep Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 65. RoLA Sleep Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 66. Row Sleep Disorders Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 67. Row Sleep Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 68. Row Sleep Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 69. List of secondary sources, used in the study of global Sleep Disorders Treatment Market
  • TABLE 70. List of primary sources, used in the study of global Sleep Disorders Treatment Market
  • TABLE 71. Years considered for the study
  • TABLE 72. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

  • FIG 1. Global Sleep Disorders Treatment Market, research methodology
  • FIG 2. Global Sleep Disorders Treatment Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Sleep Disorders Treatment Market, key trends 2021
  • FIG 5. Global Sleep Disorders Treatment Market, growth prospects 2022-2029
  • FIG 6. Global Sleep Disorders Treatment Market, porters 5 force model
  • FIG 7. Global Sleep Disorders Treatment Market, pest analysis
  • FIG 8. Global Sleep Disorders Treatment Market, value chain analysis
  • FIG 9. Global Sleep Disorders Treatment Market by segment, 2019 & 2029 (USD Billion)
  • FIG 10. Global Sleep Disorders Treatment Market by segment, 2019 & 2029 (USD Billion)
  • FIG 11. Global Sleep Disorders Treatment Market by segment, 2019 & 2029 (USD Billion)
  • FIG 12. Global Sleep Disorders Treatment Market by segment, 2019 & 2029 (USD Billion)
  • FIG 13. Global Sleep Disorders Treatment Market by segment, 2019 & 2029 (USD Billion)
  • FIG 14. Global Sleep Disorders Treatment Market, regional snapshot 2019 & 2029
  • FIG 15. North America Sleep Disorders Treatment Market 2019 & 2029 (USD Billion)
  • FIG 16. Europe Sleep Disorders Treatment Market 2019 & 2029 (USD Billion)
  • FIG 17. Asia pacific Sleep Disorders Treatment Market 2019 & 2029 (USD Billion)
  • FIG 18. Latin America Sleep Disorders Treatment Market 2019 & 2029 (USD Billion)
  • FIG 19. Global Sleep Disorders Treatment Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

目次

Global Sleep Disorders Treatment Market is valued approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2029. The sleep disorders treatment market refers to the industry that develops, produces, and markets various products and services that are used to diagnose and treat sleep disorders such as insomnia, sleep apnea, restless leg syndrome, and others. The market includes pharmaceutical drugs, medical devices, and behavioral therapies. The major driving factors for the Global Sleep Disorders Treatment Market are increasing prevalence of sleep disorders, growing aging population and increasing awareness about sleep disorders. Moreover, advancements in treatment options and favorable reimbursement policies of government are creating lucrative growth opportunity for the market over the forecast period 2022-2029.

The rising incidence of sleep disorders and the general increase in public knowledge of these conditions are factors in the market's expansion. Half of US adults report having insomnia once a month or more, according to Helsestart data on world insomnia numbers in 2022 and 2023. The West is the region most susceptible to insomnia, with about 59% of adults experiencing insomnia at some time. The same source also claimed that, among all nations, individuals in Japan, Taiwan, and Sweden struggle with insomnia the most. In the two years between 2021 and 2022, Norway had 67 more melatonin inquiries per 100,000 people than Sweden, making it the country with the most melatonin searches globally. However, the high cost of Sleep Disorders Treatment stifles market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Sleep Disorders Treatment Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is the largest market for sleep disorders treatment due to the high prevalence of sleep disorders, favorable reimbursement policies, and the presence of major players in the region. The Asia-Pacific region is expected to witness significant growth in the sleep disorders treatment market due to the rising prevalence of sleep disorders, increasing healthcare expenditure, and the presence of a large patient pool.

Major market players included in this report are:

  • Takeda Pharmaceuticals USA Inc.
  • Vanda Pharmaceuticals Inc.
  • Merck & Co.
  • Mylan NV
  • Pfizer
  • Teva Pharmaceuticals USA Inc
  • Philips Healthcare
  • ResMed
  • Fisher & Paykel Healthcare
  • GlaxoSmithKline

Recent Developments in the Market:

  • In 2021, Philips launched its DreamStation 2, a continuous positive airway pressure (CPAP) device for sleep apnea treatment. The device is designed to be smaller and quieter than its predecessor, making it more comfortable for patients to use.
  • In 2021, ResMed acquired a digital therapeutics company, Propeller Health, to expand its offerings in respiratory and sleep therapy. Propeller Health's platform uses sensors and software to help patients manage their respiratory conditions.

Global Sleep Disorders Treatment Market Report Scope:

  • Historical Data: 2019-2020-2021
  • Base Year for Estimation: 2021
  • Forecast period: 2022-2029
  • Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered: Drug Type, Application, Region
  • Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World
  • Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Drug Type offerings of key players. The detailed segments and sub-segment of the market are explained below.

By Drug Type:

  • Benzodiazepines
  • Nonbenzodiazepines
  • Antidepressants
  • Other Drug Types

By Application:

  • Insomnia
  • Sleep Apnea
  • Narcolepsy
  • Circadian disorders
  • Other Applications

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Rest of the World

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
    • 1.2.1. Sleep Disorders Treatment Market, by Region, 2019-2029 (USD Billion)
    • 1.2.2. Sleep Disorders Treatment Market, by Drug Type, 2019-2029 (USD Billion)
    • 1.2.3. Sleep Disorders Treatment Market, by Application, 2019-2029 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Sleep Disorders Treatment Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Sleep Disorders Treatment Market Dynamics

  • 3.1. Sleep Disorders Treatment Market Impact Analysis (2019-2029)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increasing prevalence of sleep disorders
      • 3.1.1.2. Growing Geriatric Population
      • 3.1.1.3. Increasing awareness about sleep disorders
    • 3.1.2. Market Challenges
      • 3.1.2.1. High Cost of Sleep Disorders Treatment
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Advancements in treatment options
      • 3.1.3.2. Favorable reimbursement policies by government

Chapter 4. Global Sleep Disorders Treatment Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
  • 4.4. Investment Adoption Model
  • 4.5. Analyst Recommendation & Conclusion
  • 4.6. Top investment opportunity
  • 4.7. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

  • 5.1. Assessment of the overall impact of COVID-19 on the industry
  • 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Sleep Disorders Treatment Market, by Drug Type

  • 6.1. Market Snapshot
  • 6.2. Global Sleep Disorders Treatment Market by Drug Type, Performance - Potential Analysis
  • 6.3. Global Sleep Disorders Treatment Market Estimates & Forecasts by Drug Type 2019-2029 (USD Billion)
  • 6.4. Sleep Disorders Treatment Market, Sub Segment Analysis
    • 6.4.1. Benzodiazepines
    • 6.4.2. Nonbenzodiazepines
    • 6.4.3. Antidepressants
    • 6.4.4. Other Drug Types

Chapter 7. Global Sleep Disorders Treatment Market, by Application

  • 7.1. Market Snapshot
  • 7.2. Global Sleep Disorders Treatment Market by Application, Performance - Potential Analysis
  • 7.3. Global Sleep Disorders Treatment Market Estimates & Forecasts by Application 2019-2029 (USD Billion)
  • 7.4. Sleep Disorders Treatment Market, Sub Segment Analysis
    • 7.4.1. Insomnia
    • 7.4.2. Sleep Apnea
    • 7.4.3. Narcolepsy
    • 7.4.4. Circadian disorders
    • 7.4.5. Other Applications

Chapter 8. Global Sleep Disorders Treatment Market, Regional Analysis

  • 8.1. Sleep Disorders Treatment Market, Regional Market Snapshot
  • 8.2. North America Sleep Disorders Treatment Market
    • 8.2.1. U.S. Sleep Disorders Treatment Market
      • 8.2.1.1. Drug Type breakdown estimates & forecasts, 2019-2029
      • 8.2.1.2. Application breakdown estimates & forecasts, 2019-2029
    • 8.2.2. Canada Sleep Disorders Treatment Market
  • 8.3. Europe Sleep Disorders Treatment Market Snapshot
    • 8.3.1. U.K. Sleep Disorders Treatment Market
    • 8.3.2. Germany Sleep Disorders Treatment Market
    • 8.3.3. France Sleep Disorders Treatment Market
    • 8.3.4. Spain Sleep Disorders Treatment Market
    • 8.3.5. Italy Sleep Disorders Treatment Market
    • 8.3.6. Rest of Europe Sleep Disorders Treatment Market
  • 8.4. Asia-Pacific Sleep Disorders Treatment Market Snapshot
    • 8.4.1. China Sleep Disorders Treatment Market
    • 8.4.2. India Sleep Disorders Treatment Market
    • 8.4.3. Japan Sleep Disorders Treatment Market
    • 8.4.4. Australia Sleep Disorders Treatment Market
    • 8.4.5. South Korea Sleep Disorders Treatment Market
    • 8.4.6. Rest of Asia Pacific Sleep Disorders Treatment Market
  • 8.5. Latin America Sleep Disorders Treatment Market Snapshot
    • 8.5.1. Brazil Sleep Disorders Treatment Market
    • 8.5.2. Mexico Sleep Disorders Treatment Market
  • 8.6. Rest of The World Sleep Disorders Treatment Market

Chapter 9. Competitive Intelligence

  • 9.1. Top Market Strategies
  • 9.2. Company Profiles
    • 9.2.1. Takeda Pharmaceuticals USA Inc.
      • 9.2.1.1. Key Information
      • 9.2.1.2. Overview
      • 9.2.1.3. Financial (Subject to Data Availability)
      • 9.2.1.4. Product Summary
      • 9.2.1.5. Recent Developments
    • 9.2.2. Vanda Pharmaceuticals Inc.
    • 9.2.3. Merck & Co.
    • 9.2.4. Mylan NV
    • 9.2.5. Pfizer
    • 9.2.6. Teva Pharmaceuticals USA Inc
    • 9.2.7. Philips Healthcare
    • 9.2.8. ResMed
    • 9.2.9. Fisher & Paykel Healthcare
    • 9.2.10. GlaxoSmithKline

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
  • 10.3. Research Assumption